Will PayPal Stock Recover or Keep Sliding?
Payments platform behemoth PayPal Holdings, Inc. (NASDAQ:PYPL) is going through…
Buy
52
ALGN Quote, Financials, Valuation and Earnings
Last price:
$180.00
Seasonality move
:
10.89%
Day range:
$171.64 - $175.40
52-week range:
$141.74 - $327.49
Dividend yield:
0%
P/E ratio:
30.99x
P/S ratio:
3.26x
P/B ratio:
3.32x
Volume:
1.4M
Avg. volume:
1.4M
1-year change:
-42.2%
Market cap:
$12.8B
Revenue:
$4B
EPS (TTM):
$5.61
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
ALGN
Align Technology
|
$975M | $1.99 | -1.71% | 44.8% | $234.70 |
|
BSX
Boston Scientific
|
$4.6B | $0.67 | 16.07% | 222.09% | $114.78 |
|
NVST
Envista Holdings
|
$607.7M | $0.21 | -2.29% | 51.15% | $20.25 |
|
RMD
ResMed
|
$1.3B | $2.36 | 7.21% | 15.65% | $265.42 |
|
STE
Steris PLC
|
$1.5B | $2.60 | 3.71% | 63.48% | $250.11 |
|
XRAY
Dentsply Sirona
|
$854.4M | $0.30 | -7.12% | 230.39% | $18.57 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
ALGN
Align Technology
|
$173.87 | $234.70 | $12.8B | 30.99x | $0.00 | 0% | 3.26x |
|
BSX
Boston Scientific
|
$95.05 | $114.78 | $140.3B | 76.04x | $0.00 | 0% | 8.43x |
|
NVST
Envista Holdings
|
$15.17 | $20.25 | $2.6B | -- | $0.00 | 0% | 1.04x |
|
RMD
ResMed
|
$214.08 | $265.42 | $31.4B | 25.28x | $0.53 | 0.97% | 6.41x |
|
STE
Steris PLC
|
$222.77 | $250.11 | $21.9B | 47.30x | $0.57 | 1% | 4.10x |
|
XRAY
Dentsply Sirona
|
$13.02 | $18.57 | $2.6B | -- | $0.16 | 4.92% | 0.70x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
ALGN
Align Technology
|
-- | 2.064 | -- | 1.02x |
|
BSX
Boston Scientific
|
32.79% | 0.797 | 8.05% | 0.46x |
|
NVST
Envista Holdings
|
32.21% | 1.303 | 41.98% | 1.63x |
|
RMD
ResMed
|
11.35% | 0.237 | 2% | 1.74x |
|
STE
Steris PLC
|
25.22% | 0.755 | 10.71% | 1.20x |
|
XRAY
Dentsply Sirona
|
52.37% | 0.294 | 56.57% | 0.55x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
ALGN
Align Technology
|
$696.9M | $177.1M | 11.12% | 11.12% | 17.79% | $263.1M |
|
BSX
Boston Scientific
|
$3.1B | $790M | 5.97% | 8.96% | 14.58% | $1.2B |
|
NVST
Envista Holdings
|
$372.5M | $67.7M | -22.7% | -32.33% | 7.11% | $123.8M |
|
RMD
ResMed
|
$751.3M | $417.2M | 21.74% | 25.56% | 32.54% | $285.2M |
|
STE
Steris PLC
|
$610.3M | $247.5M | 5.15% | 7.27% | 18.08% | $243.6M |
|
XRAY
Dentsply Sirona
|
$446M | $9M | -18.42% | -32.39% | -56.02% | $36M |
Align Technology vs. Competitors
-
Which has Higher Returns ALGN or BSX?
Boston Scientific has a net margin of 10.43% compared to Align Technology's net margin of 12.41%. Align Technology's return on equity of 11.12% beat Boston Scientific's return on equity of 8.96%.
Company Gross Margin Earnings Per Share Invested Capital ALGNAlign Technology70.03% $1.39 $3.9B BSXBoston Scientific67.86% $0.38 $32.6B -
What do Analysts Say About ALGN or BSX?
Align Technology has a consensus price target of $234.70, signalling upside risk potential of 34.99%. On the other hand Boston Scientific has an analysts' consensus of $114.78 which suggests that it could grow by 20.75%. Given that Align Technology has higher upside potential than Boston Scientific, analysts believe Align Technology is more attractive than Boston Scientific.
Company Buy Ratings Hold Ratings Sell Ratings ALGNAlign Technology9 5 0 BSXBoston Scientific22 4 0 -
Is ALGN or BSX More Risky?
Align Technology has a beta of 1.728, which suggesting that the stock is 72.834% more volatile than S&P 500. In comparison Boston Scientific has a beta of 0.728, suggesting its less volatile than the S&P 500 by 27.188%.
-
Which is a Better Dividend Stock ALGN or BSX?
Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Align Technology pays -- of its earnings as a dividend. Boston Scientific pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ALGN or BSX?
Align Technology quarterly revenues are $995.2M, which are smaller than Boston Scientific quarterly revenues of $4.6B. Align Technology's net income of $103.8M is lower than Boston Scientific's net income of $566M. Notably, Align Technology's price-to-earnings ratio is 30.99x while Boston Scientific's PE ratio is 76.04x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 3.26x versus 8.43x for Boston Scientific. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ALGNAlign Technology3.26x 30.99x $995.2M $103.8M BSXBoston Scientific8.43x 76.04x $4.6B $566M
-
Which has Higher Returns ALGN or NVST?
Envista Holdings has a net margin of 10.43% compared to Align Technology's net margin of 0.18%. Align Technology's return on equity of 11.12% beat Envista Holdings's return on equity of -32.33%.
Company Gross Margin Earnings Per Share Invested Capital ALGNAlign Technology70.03% $1.39 $3.9B NVSTEnvista Holdings57.05% $0.01 $4.3B -
What do Analysts Say About ALGN or NVST?
Align Technology has a consensus price target of $234.70, signalling upside risk potential of 34.99%. On the other hand Envista Holdings has an analysts' consensus of $20.25 which suggests that it could grow by 33.49%. Given that Align Technology has higher upside potential than Envista Holdings, analysts believe Align Technology is more attractive than Envista Holdings.
Company Buy Ratings Hold Ratings Sell Ratings ALGNAlign Technology9 5 0 NVSTEnvista Holdings3 10 1 -
Is ALGN or NVST More Risky?
Align Technology has a beta of 1.728, which suggesting that the stock is 72.834% more volatile than S&P 500. In comparison Envista Holdings has a beta of 1.120, suggesting its more volatile than the S&P 500 by 12.044%.
-
Which is a Better Dividend Stock ALGN or NVST?
Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Envista Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Align Technology pays -- of its earnings as a dividend. Envista Holdings pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ALGN or NVST?
Align Technology quarterly revenues are $995.2M, which are larger than Envista Holdings quarterly revenues of $652.9M. Align Technology's net income of $103.8M is higher than Envista Holdings's net income of $1.2M. Notably, Align Technology's price-to-earnings ratio is 30.99x while Envista Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 3.26x versus 1.04x for Envista Holdings. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ALGNAlign Technology3.26x 30.99x $995.2M $103.8M NVSTEnvista Holdings1.04x -- $652.9M $1.2M
-
Which has Higher Returns ALGN or RMD?
ResMed has a net margin of 10.43% compared to Align Technology's net margin of 26.88%. Align Technology's return on equity of 11.12% beat ResMed's return on equity of 25.56%.
Company Gross Margin Earnings Per Share Invested Capital ALGNAlign Technology70.03% $1.39 $3.9B RMDResMed58.6% $2.34 $5.9B -
What do Analysts Say About ALGN or RMD?
Align Technology has a consensus price target of $234.70, signalling upside risk potential of 34.99%. On the other hand ResMed has an analysts' consensus of $265.42 which suggests that it could grow by 23.98%. Given that Align Technology has higher upside potential than ResMed, analysts believe Align Technology is more attractive than ResMed.
Company Buy Ratings Hold Ratings Sell Ratings ALGNAlign Technology9 5 0 RMDResMed8 6 1 -
Is ALGN or RMD More Risky?
Align Technology has a beta of 1.728, which suggesting that the stock is 72.834% more volatile than S&P 500. In comparison ResMed has a beta of 0.755, suggesting its less volatile than the S&P 500 by 24.514%.
-
Which is a Better Dividend Stock ALGN or RMD?
Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ResMed offers a yield of 0.97% to investors and pays a quarterly dividend of $0.53 per share. Align Technology pays -- of its earnings as a dividend. ResMed pays out 27.65% of its earnings as a dividend. ResMed's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ALGN or RMD?
Align Technology quarterly revenues are $995.2M, which are smaller than ResMed quarterly revenues of $1.3B. Align Technology's net income of $103.8M is lower than ResMed's net income of $344.6M. Notably, Align Technology's price-to-earnings ratio is 30.99x while ResMed's PE ratio is 25.28x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 3.26x versus 6.41x for ResMed. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ALGNAlign Technology3.26x 30.99x $995.2M $103.8M RMDResMed6.41x 25.28x $1.3B $344.6M
-
Which has Higher Returns ALGN or STE?
Steris PLC has a net margin of 10.43% compared to Align Technology's net margin of 12.66%. Align Technology's return on equity of 11.12% beat Steris PLC's return on equity of 7.27%.
Company Gross Margin Earnings Per Share Invested Capital ALGNAlign Technology70.03% $1.39 $3.9B STESteris PLC44.53% $1.75 $8.6B -
What do Analysts Say About ALGN or STE?
Align Technology has a consensus price target of $234.70, signalling upside risk potential of 34.99%. On the other hand Steris PLC has an analysts' consensus of $250.11 which suggests that it could grow by 12.27%. Given that Align Technology has higher upside potential than Steris PLC, analysts believe Align Technology is more attractive than Steris PLC.
Company Buy Ratings Hold Ratings Sell Ratings ALGNAlign Technology9 5 0 STESteris PLC3 4 0 -
Is ALGN or STE More Risky?
Align Technology has a beta of 1.728, which suggesting that the stock is 72.834% more volatile than S&P 500. In comparison Steris PLC has a beta of 0.873, suggesting its less volatile than the S&P 500 by 12.657%.
-
Which is a Better Dividend Stock ALGN or STE?
Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Steris PLC offers a yield of 1% to investors and pays a quarterly dividend of $0.57 per share. Align Technology pays -- of its earnings as a dividend. Steris PLC pays out 53.03% of its earnings as a dividend. Steris PLC's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ALGN or STE?
Align Technology quarterly revenues are $995.2M, which are smaller than Steris PLC quarterly revenues of $1.4B. Align Technology's net income of $103.8M is lower than Steris PLC's net income of $173.5M. Notably, Align Technology's price-to-earnings ratio is 30.99x while Steris PLC's PE ratio is 47.30x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 3.26x versus 4.10x for Steris PLC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ALGNAlign Technology3.26x 30.99x $995.2M $103.8M STESteris PLC4.10x 47.30x $1.4B $173.5M
-
Which has Higher Returns ALGN or XRAY?
Dentsply Sirona has a net margin of 10.43% compared to Align Technology's net margin of -47.51%. Align Technology's return on equity of 11.12% beat Dentsply Sirona's return on equity of -32.39%.
Company Gross Margin Earnings Per Share Invested Capital ALGNAlign Technology70.03% $1.39 $3.9B XRAYDentsply Sirona49.28% -$2.16 $4.1B -
What do Analysts Say About ALGN or XRAY?
Align Technology has a consensus price target of $234.70, signalling upside risk potential of 34.99%. On the other hand Dentsply Sirona has an analysts' consensus of $18.57 which suggests that it could grow by 42.64%. Given that Dentsply Sirona has higher upside potential than Align Technology, analysts believe Dentsply Sirona is more attractive than Align Technology.
Company Buy Ratings Hold Ratings Sell Ratings ALGNAlign Technology9 5 0 XRAYDentsply Sirona2 13 0 -
Is ALGN or XRAY More Risky?
Align Technology has a beta of 1.728, which suggesting that the stock is 72.834% more volatile than S&P 500. In comparison Dentsply Sirona has a beta of 0.918, suggesting its less volatile than the S&P 500 by 8.232%.
-
Which is a Better Dividend Stock ALGN or XRAY?
Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Dentsply Sirona offers a yield of 4.92% to investors and pays a quarterly dividend of $0.16 per share. Align Technology pays -- of its earnings as a dividend. Dentsply Sirona pays out -13.85% of its earnings as a dividend.
-
Which has Better Financial Ratios ALGN or XRAY?
Align Technology quarterly revenues are $995.2M, which are larger than Dentsply Sirona quarterly revenues of $905M. Align Technology's net income of $103.8M is higher than Dentsply Sirona's net income of -$430M. Notably, Align Technology's price-to-earnings ratio is 30.99x while Dentsply Sirona's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 3.26x versus 0.70x for Dentsply Sirona. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ALGNAlign Technology3.26x 30.99x $995.2M $103.8M XRAYDentsply Sirona0.70x -- $905M -$430M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Will Eli Lilly Stock Go By 2030?
The weight loss drugs market is heating up quickly and…
Is TSMC the Best Semiconductor Stock to Buy Now?
The new administration has launched a slew of tariffs, paused…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Sell
47
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 31x
Sell
42
Is NVDA Stock a Buy?
Market Cap: $2.4T
P/E Ratio: 34x
Alerts
Buy
56
ROOT alert for Apr 23
Root [ROOT] is up 10.99% over the past day.
Buy
72
EFX alert for Apr 23
Equifax [EFX] is up 1.75% over the past day.
Buy
51
CALX alert for Apr 23
Calix [CALX] is down 1.94% over the past day.
